Flu Vaccine Reduces Risk of Dying for Elderly Intensive Care

Article

It appears that an influenza vaccine does not just work when it comes to influenza. A new study shows that elderly people who have been admitted to an intensive care units have less risk of dying and of suffering a blood clot or bleeding in the brain if they have been vaccinated.

It appears that an influenza vaccine does not just work when it comes to influenza. A new study shows that elderly people who have been admitted to an intensive care units have less risk of dying and of suffering a blood clot or bleeding in the brain if they have been vaccinated. And this is despite the fact that they are typically older, have more chronic diseases and take more medicine then those who have not been vaccinated.

It appears that an influenza vaccine does not just work when it comes to influenza. A new study shows that elderly people who have been admitted to an intensive care units have less risk of dying and of suffering a blood clot or bleeding in the brain if they have been vaccinated. And this is despite the fact that they are typically older, have more chronic diseases and take more medicine then those who have not been vaccinated.

The study covers almost 90,000 surviving intensive care patients above the age of 65 during an 11-year period in Denmark. Only a few of them were admitted directly due to influenza. However, regardless of the cause of the admission, for those who were vaccinated the risk of suffering a stroke-- which is the collective name for bleeding and blood clots in the brain - was 16 percent lower. This group also has an eight per cent lower risk of dying during the first year following their hospitalization.

"Every year, 30,000 people are admitted to the intensive care units in Danish hospitals and we know that the first year is critical. Approximately three out of four survive the hospitalisation and are discharged from the hospital. But even among the patients who are discharged, almost one in five die within the first year while many others suffer complications. Our study shows that there are fewer deaths and serious complications among the patients who have been vaccinated against influenza. So this supports the current recommendation that elderly people should be vaccinated," says Christian Fynbo Christiansen, clinical associate professor at Aarhus University Hospital and consultant at Aarhus University Hospital, Denmark.

Today, less than 40 percent of elderly Europeans say yes to the vaccination.

"We can't say with 100 percent certainty that the risk of a stroke and dying is lower solely because of the vaccine. But we can see that the elderly people who have been vaccinated do better in the event of critical illness. This suggests that it would be good if more elderly people received the vaccine. Not least because the vaccine is both safe and inexpensive," says Christiansen.

This is the first time that researchers have looked into the effect of the vaccine specifically on elderly critically ill patients. Other researchers have previously shown that the influenza vaccine lessens the risk of bacterial infections and heart attacks. However, the study shows that this is not the case for the elderly intensive care patients.

"Surprisingly, the vaccine didn't reduce the number of pneumonia cases in our study. We had otherwise expect that it would, as some previous studies have shown that the vaccine has this effect on younger and healthy individuals. Neither was there any clear difference in the number of blood clots in the heart. This raises new research questions about what effect of the vaccine on the immune system and whether there were other differences between the patients," says Christiansen.

Source: Aarhus University

 

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content